Home > Insider Trading > Filing (0001235802-22-000136)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1427570	Reshape Lifesciences Inc.	RSLS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1181166	Thomas Stankovich	1001 Calle Amanecer San Clemente CA 92673	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $0.001 Par Value Per Share	Acquisiton	2022-11-17	364,756	$0.00	697,517	No	4	A	Direct
Common Stock, $0.001 Par Value Per Share	Disposition	2022-11-28	364,756	$0.17	332,761	No	4	S	Direct
Common Stock, $0.001 Par Value Per Share	Disposition	2022-12-01	5,144	$0.15	327,617	No	4	S	Direct
Common Stock, $0.001 Par Value Per Share	Disposition	2022-12-01	2,213	$0.15	325,404	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

These shares were issued pursuant to a stock bonus granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan.
These shares were sold to cover taxes and fees in connection with the stock bonus.
On July 22, 2021, Mr. Stankovich was awarded an aggregate of 372,744 restricted stock units, all of which, including the unvested portion, were reported on a Form 4 filed on September 17, 2021. The shares reported under this Form 4 as being disposed of were sold to cover taxes in connection with the vesting of a portion of those previously reported restricted stock units.